This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1978 Mar;19(3):330-1.

Quantification of skeletal Tc-99m labeled phosphates to defect metabolic bone disease

PMID: 632914

Free article

Editorial

Quantification of skeletal Tc-99m labeled phosphates to defect metabolic bone disease

R A Holmes. J Nucl Med. 1978 Mar.

Free article

. 1978 Mar;19(3):330-1.

Author

PMID: 632914

No abstract available

PubMed Disclaimer

Similar articles

Clinical spectrum and diagnostic pitfalls of multiple abnormal uptakes on bone scintigraphy.
Tsubaki F, Kurata S, Nagata S, Fujimoto K, Abe T. Tsubaki F, et al. Jpn J Radiol. 2016 Dec;34(12):771-778. doi: 10.1007/s11604-016-0585-8. Epub 2016 Sep 29. Jpn J Radiol. 2016. PMID: 27688157 Review.
[Importance of bone scintigraphy in skeletal diseases].
Silvestro L, Bona G, Leonessa M, Giusti M, Mussa GC. Silvestro L, et al. Minerva Pediatr. 1983 Nov 15;35(21):1051-7. Minerva Pediatr. 1983. PMID: 6231466 Italian. No abstract available.
What do we want from a bone-scanning agent?
Fogelman I, Bessent RG. Fogelman I, et al. J Nucl Med. 1980 Mar;21(3):296. J Nucl Med. 1980. PMID: 6445001 No abstract available.
The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR. Fogelman I, et al. J Nucl Med. 1978 Mar;19(3):270-5. J Nucl Med. 1978. PMID: 564941
Technetium-99m labeled agents for skeletal imaging.
Thrall JH. Thrall JH. CRC Crit Rev Clin Radiol Nucl Med. 1976;8(1):1-31. CRC Crit Rev Clin Radiol Nucl Med. 1976. PMID: 789010 Review.

See all similar articles

Cited by

[¹⁷⁷Lu]Lu-EDTMP -a bone pain palliating agent: pharmacokinetics, biodistribution, safety profile and clinical evaluation in osseous metastatic patients.
Saeed S, Paez D, Estrada Lobato E, Delgado Bolton RC, Jameel G, Qureshi F, Pellet O, Brink A, Soto A, Grigoryan A, Knoll P, Giammarile F. Saeed S, et al. Eur J Nucl Med Mol Imaging. 2025 Aug;52(10):3757-3772. doi: 10.1007/s00259-025-07218-x. Epub 2025 Apr 2. Eur J Nucl Med Mol Imaging. 2025. PMID: 40172696 Free PMC article. Clinical Trial.
Skeletal scintigraphy.
McDougall IR. McDougall IR. West J Med. 1979 Jun;130(6):503-14. West J Med. 1979. PMID: 390886 Free PMC article. Review.
Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.
Knop J, Kröger E, Stritzke P, Schneider C, Kruse HP. Knop J, et al. Eur J Nucl Med. 1981 Feb;6(2):63-7. doi: 10.1007/BF00253715. Eur J Nucl Med. 1981. PMID: 6451429
A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease.
Fogelman I, Bessent RG, Gordon D. Fogelman I, et al. Eur J Nucl Med. 1981 Mar;6(3):93-7. doi: 10.1007/BF00266417. Eur J Nucl Med. 1981. PMID: 6783412
Bone scanning in the child and young adult. Part I.
Murray IP. Murray IP. Skeletal Radiol. 1980 Feb;5(1):1-14. doi: 10.1007/BF00347091. Skeletal Radiol. 1980. PMID: 6965804

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire